Zhejiang Jiuzhou Pharmaceutical Co., Ltd

SHSE:603456 Stock Report

Market Cap: CN¥14.5b

Zhejiang Jiuzhou Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Zhejiang Jiuzhou Pharmaceutical has a total shareholder equity of CN¥8.7B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 19.5%. Its total assets and total liabilities are CN¥12.2B and CN¥3.5B respectively. Zhejiang Jiuzhou Pharmaceutical's EBIT is CN¥974.7M making its interest coverage ratio -11.2. It has cash and short-term investments of CN¥4.1B.

Key information

19.5%

Debt to equity ratio

CN¥1.70b

Debt

Interest coverage ratio-11.2x
CashCN¥4.06b
EquityCN¥8.74b
Total liabilitiesCN¥3.51b
Total assetsCN¥12.25b

Recent financial health updates

No updates

Recent updates

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next

Apr 11
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate

Feb 28
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate

Financial Position Analysis

Short Term Liabilities: 603456's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥2.8B).

Long Term Liabilities: 603456's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥697.3M).


Debt to Equity History and Analysis

Debt Level: 603456 has more cash than its total debt.

Reducing Debt: 603456's debt to equity ratio has increased from 2.7% to 19.5% over the past 5 years.

Debt Coverage: 603456's debt is well covered by operating cash flow (45%).

Interest Coverage: 603456 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.